Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions. | Nucleic Acids Res | 2022 | 36537190 | PubTator, text mining | PubMed |
| Critical analysis of the hypothesized SNHG1/miR-195-5p/YAP1 axis. | Funct Integr Genomics | 2022 | 36526938 | PubTator, text mining | PubMed |
| Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis. | Transl Cancer Res | 2022 | 36523305 | PubTator, text mining | PubMed |
| Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence. | Nat Commun | 2022 | 36522333 | PubTator, text mining | PubMed |
| STYK1/NOK affects cell cycle late mitosis and directly interacts with anaphase-promoting complex activator CDH1. | Heliyon | 2022 | 36506394 | PubTator, text mining | PubMed |
| Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation. | Front Genet | 2022 | 36506302 | PubTator, text mining | PubMed |
| Evaluating the Expression and Prognostic Value of Genes Encoding Microtubule-Associated Proteins in Lung Cancer. | Int J Mol Sci | 2022 | 36499051 | PubTator, text mining | PubMed |
| Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers. | Cell Div | 2022 | 36494865 | PubTator, text mining | PubMed |
| Alzheimer's risk factor FERMT2 promotes the progression of colorectal carcinoma via Wnt/β-catenin signaling pathway and contributes to the negative correlation between Alzheimer and cancer. | PLoS One | 2022 | 36480537 | PubTator, text mining | PubMed |
| Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis. | Front Oncol | 2022 | 36479068 | PubTator, text mining | PubMed |
| ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. | Int J Gen Med | 2022 | 36465268 | PubTator, text mining | PubMed |
| Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours. | Sci Rep | 2022 | 36463288 | PubTator, text mining | PubMed |
| In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model. | Int J Pharm X | 2022 | 36420371 | PubTator, text mining | PubMed |
| Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer. | Clin Transl Med | 2022 | 36394206 | PubTator, text mining | PubMed |
| ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. | Front Oncol | 2022 | 36387165 | PubTator, text mining | PubMed |
| Circular RNAs as diagnostic biomarkers for gastric cancer: A comprehensive update from emerging functions to clinical significances. | Front Genet | 2022 | 36386850 | PubTator, text mining | PubMed |
| HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial. | EBioMedicine | 2022 | 36374768 | PubTator, text mining | PubMed |
| Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. | Int J Mol Sci | 2022 | 36362392 | PubTator, text mining | PubMed |
| CircRNAs in Tumor Radioresistance. | Biomolecules | 2022 | 36358938 | PubTator, text mining | PubMed |
| Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery. | Pharmaceuticals (Basel) | 2022 | 36355497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=18